Deutsche Bank Ag\ Reneo Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.96 - $3.04 $9,255 - $14,354	-4,722 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.94 - $9.07 $1,646 - $5,079	-560 Reduced 10.6%	4,722 $14,000
Q4 2021 Feb 11, 2022	BUY	$6.07 - $9.68 $10,051 - $16,030	1,656 Added 45.67%	5,282 $45,000
Q3 2021 Nov 04, 2021	SELL	$6.28 - $11.07 $747 - $1,317	-119 Reduced 3.18%	3,626 $27,000
Q2 2021 Aug 11, 2021	BUY	$7.78 - $15.0 $29,136 - $56,175	3,745 New	3,745 $35,000

31M

50.8K

Ticker RPHM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,479,600
Market Cap $41.1M
Description
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.